Related Experiment Video
Updated: Jan 22, 2026

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
Published on: January 28, 2021
Current and future role of lipoprotein(a) in preventive cardiology
Adam N Berman1,2, Ron Blankstein1,2
1Cardiovascular Division, Department of Medicine.
Insights
Lipoprotein(a) [Lp(a)] significantly increases cardiovascular risk due to its genetic basis. Emerging therapies targeting Lp(a) show promise for preventing atherosclerotic cardiovascular disease (ASCVD).
Area of Science:
- Cardiovascular Medicine
- Genetics
- Pharmacology
Background:
- Elevated lipoprotein(a) [Lp(a)] is a significant, genetically determined risk factor for atherosclerotic cardiovascular disease (ASCVD), coronary heart disease, calcific aortic valve stenosis, and ischemic stroke.
- Lp(a) contributes to residual cardiovascular risk even when other risk factors are controlled.
- The unique structure of Lp(a), involving apolipoprotein(a), influences its pathogenicity and measurement challenges.
Purpose of the Study:
- To review the current understanding of lipoprotein(a) [Lp(a)] in atherosclerotic cardiovascular disease (ASCVD).
- To explore the structure-function relationship of Lp(a).
- To highlight promising therapeutic developments targeting Lp(a).
Main Methods:
- This is a review article, synthesizing existing research and clinical findings.
- Focuses on the genetic basis and pathogenic mechanisms of Lp(a).
- Examines the current and emerging therapeutic landscape for Lp(a)-associated risk.
Main Results:
- High Lp(a) levels are strongly and independently linked to increased ASCVD risk.
- Genetic factors predominantly determine Lp(a) levels.
- Emerging therapies targeting apolipoprotein(a) demonstrate potential for Lp(a) management.
Conclusions:
- Lipoprotein(a) [Lp(a)] is a critical factor in atherosclerotic cardiovascular disease (ASCVD) risk.
- Targeted therapies for Lp(a) offer a new avenue for cardiovascular disease prevention.
- Further research and clinical application of these therapies are anticipated.
Purpose Of Review:
The purpose of this review is to highlight our emerging understanding of lipoprotein(a) [Lp(a)]'s role in atherosclerotic cardiovascular disease (ASCVD), its structure-function relationship, and promising developments within the therapeutic pipeline.
Recent Findings:
Elevated levels of Lp(a) are strongly associated with an increased risk of coronary heart disease, calcific aortic valve stenosis, and ischemic stroke. With circulating levels almost exclusively genetically mediated, increased levels of Lp(a) contribute significantly to the residual cardiovascular disease risk in individuals with otherwise well controlled risk factors. The unique structure of Lp(a) - comprised of a genetically heterogeneous apolipoprotein(a) molecule bound to an LDL-like moiety - provides insight into its pathogenic role in cardiovascular disease and also complicates its accurate measurement. Emerging therapies targeting the apolipoprotein(a) component of Lp(a) have the potential to revolutionize the management of individuals with elevated Lp(a).
Summary:
With promising therapies on the horizon, there has been a renewed focus on the role of Lp(a) in ASCVD. Given Lp(a)'s strong and independent association with key cardiovascular outcomes, it is hopeful that these promising targeted therapies will add another therapeutic option for the prevention of cardiovascular disease.
Related Concept Videos
Cancer Prevention
Some...
Prevention of Further Absorption of Poison
Preventive Healthcare Services
Electrical Current
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

